Who
Bilal Arshad Khan
Director
Company insider
Files Form 4 as: Director, SpyGlass Pharma.
In numbers
- Trades disclosed
- 6
- Buys
- 1
- Sells
- 0
- Bought
- $4.3M
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 5 Feb 2026
- Last trade
- 9 Feb 2026
- Last filed
- 11 Feb 2026
Companies traded
Activity over time
1 Feb – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Bought | $320K20,000 at $16.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Bought | $1.8M115,000 at $16.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Bought | $320K20,000 at $16.00 | filing |
| 9 Feb 2026filed 11 Feb 2026 | SGP SpyGlass PharmaMedical Devices | SEC FORM 4 Bought | $1.8M115,000 at $16.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code A | —13,700 at $0.00 | filing |
| 5 Feb 2026filed 9 Feb 2026 | SGP SpyGlass Pharmaoption or derivative · Medical Devices | SEC FORM 4 Code A | —13,700 at $0.00 | filing |
News
SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL SystemSGP · manilatimes.net · 19 Oct 2026
0 headlines in the last 90 days name Bilal Arshad Khan; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.